The US nutrition and Drug Administ...

The US nutrition and Drug Administration is count uponed to complete its review of mifepristone (ie, RU-486) an alternative to early surgical abortion, in the nearest year, according to a clan 16, 1998, press release from the Kaiser Family Foundation. A national inspect of obstetricians and gynecologists indicates that 54% of respondent are "very" or "somewhat" likely to prescribe mifepristone, if approved, for patients seeking abortions, including almost 45% of respondent who generally do not provide surgical abortions.

The release states that 45% of family practice physicians and 54% of feed at the breast practitioners and physician assistants also expres interest in offering mifepristone if approved, which could expand the number of providers who furnish some form of abortion. Three percent of family practice physicians and 2% of nourish practitioners and physician assistants responding to the scrutinize reported "ever performing" surgical abortion.

According to the release, mifepristone has been used by way of more than 500,000 women in Europe including France, England, and Sweden, where the medication has been available for almost a decade. The medication has been available to a limited number of women in the United States participating in clinical trials.

National measure and estimate of Women's Health Care Providers upon Medical Abortion (press release, Menlo Park, Calif: Kaiser Family Foundation, family 16, 1998) 1-2. Available at http://www.kff.org/archive/repro/briefing/ru486_rel.html. Accessed 21 race 1998.

COPYRIGHT 1998 Association of Operating compass Nurses, Inc.

COPYRIGHT 2001 Gale Group